Anthony A. Rayner

3.7k citations
44 papers · 3.1k · 1 hit paper · h-index 23

Impact in

  • Immunology top 2%
    • Immune Cell Function and Interaction
    • Immunotherapy and Immune Responses
    • T-cell and B-cell Immunology
  • Hepatology top 2%
    • Hepatocellular Carcinoma Treatment and Prognosis

Papers in

    • Cancer Immunotherapy and Biomarkers 11
    • CAR-T cell therapy research 10
    • Pancreatic and Hepatic Oncology Research 3
    • Immune Cell Function and Interaction 14
    • Immunotherapy and Immune Responses 9

Anthony A. Rayner

43 papers receiving 2.9k citations

Anthony A. Rayner's Hit Papers

In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2. 1985 · 524 citations
5240+13+27Years since publication100200300400500

Peers

Anthony A. Rayner
Comparison fields: 5 of 122
  • Immunology 1.4k
  • Hepatology 442
  • Oncology 1.2k
  • Hematology 153
  • Biotechnology 107
Replace Heinz Regele with:
Heinz Regele Austria
S Thiru United Kingdom
Bernard Charpentier France
Matthew H. Levine United States
Kenneth A. Newell United States
Irene Schmid Germany
Norio Yoshimura Japan
FC Breedveld Netherlands
Elizabeth A. Sugar United States
Thasia Woodworth United States
Anthony A. Rayner relative to Heinz Regele Austria Heinz Regele's profile →
Citations per field
00.5×2.8×
Heinz Regele · 1×
Citations per year

Countries citing papers authored by Anthony A. Rayner

Since Specialization
Citations

This map shows the geographic impact of Anthony A. Rayner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony A. Rayner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony A. Rayner more than expected).

Fields of papers citing papers by Anthony A. Rayner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony A. Rayner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony A. Rayner. The network helps show where Anthony A. Rayner may publish in the future.

Co-authors

The 25 scholars most cited alongside Anthony A. Rayner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anthony A. Rayner Line = papers co-authored together Anthony A. Rayner links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.

#Work
1
In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2.
Hit paper breakdown →
1985524
2 1989377
3 1986310
4 1989287
5 1990175
6
Circulating cytokines in patients with metastatic cancer treated with recombinant interleukin 2 and lymphokine-activated killer cells.
1988175
7 1986117
8 1981109
9 1985108
10 1987100
11 199177
12 199076
13 199074
14
Laboratory correlates of adoptive immunotherapy with recombinant interleukin-2 and lymphokine-activated killer cells in humans.
198872
15 198568
16 199062
17 201750
18 198643
19 198740
20 199428

About Anthony A. Rayner

Anthony A. Rayner is a scholar working on Oncology, Immunology, Pulmonary and Respiratory Medicine, Surgery and Hepatology, having authored 44 papers that have together received 3.1k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (14 papers), Cancer Immunotherapy and Biomarkers (11 papers), CAR-T cell therapy research (10 papers), Immunotherapy and Immune Responses (9 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Gastric Cancer Management and Outcomes (4 papers) and Pancreatic and Hepatic Oncology Research (3 papers). The work is most often cited by research in Immunology (1.4k citations), Hepatology (442 citations), Oncology (1.2k citations), Hematology (153 citations) and Biotechnology (107 citations). Anthony A. Rayner has collaborated with scholars based in United States, Malaysia and Australia. Frequent co-authors include Michael T. Lotze, Steven A. Rosenberg, Claudia A. Seipp, Yvedt L. Matory, Stephen E. Ettinghausen, B.J. Lewis, Brett T. Gemlo, Robert Stagg, S O Sharrow and Mary Custer. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute, Journal of Surgical Oncology, Cancer and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact